CN105031481A - Pharmaceutic preparation for treating neurasthenia - Google Patents
Pharmaceutic preparation for treating neurasthenia Download PDFInfo
- Publication number
- CN105031481A CN105031481A CN201510600726.3A CN201510600726A CN105031481A CN 105031481 A CN105031481 A CN 105031481A CN 201510600726 A CN201510600726 A CN 201510600726A CN 105031481 A CN105031481 A CN 105031481A
- Authority
- CN
- China
- Prior art keywords
- parts
- treatment
- radix
- pharmaceutical preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010003549 asthenia Diseases 0.000 title claims abstract description 16
- 208000007443 Neurasthenia Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 241000157856 Cephalanthus Species 0.000 claims abstract description 9
- 241000123870 Geum aleppicum Species 0.000 claims abstract description 9
- 235000014266 Geum aleppicum Nutrition 0.000 claims abstract description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 17
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 238000005507 spraying Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000062241 Kaempferia galanga Species 0.000 abstract 1
- 235000013421 Kaempferia galanga Nutrition 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000736239 Ruellia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000002398 materia medica Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 9
- 230000003340 mental effect Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010043269 Tension headache Diseases 0.000 description 2
- 208000008548 Tension-Type Headache Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000207965 Acanthaceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241001084585 Asystasiella neesiana Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040026 Sensory disturbance Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of Chinese materia medica preparations and particularly provides a pharmaceutic preparation for treating neurasthenia. The pharmaceutic preparation is made from 20 parts of ruellia neesiana, 25 parts of geum aleppicum, 18 parts of dwarf galangal rhizome, 25 parts of buttonbush, 25 parts of roots of red-rooted salvia, 28 parts of astragalus membranaceus, 15 parts of spina date seeds, 15 parts of polygala tenuifolia, 20 parts of rhizoma acori graminei, 25 parts of schisandra chinensis, 20 parts of poria with hostwood, 25 parts of fruits of Chinese wolfberry, 20 parts of semen coicis, 15 parts of dogwood, 15 parts of chrysanthemums, 15 parts of uncaria, 25 parts of tuber fleeceflower stems, 15 parts of caulis spatholobi and 5 parts of liquorice. The pharmaceutic preparation is capable of treating neurasthenia.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to one and be used for the treatment of neurasthenic pharmaceutical preparation and its preparation method and application.
Background technology
Neurasthenia is a more wide in range appellation, calls it at present like this and comprises a part depression, anxiety disorder, tension headache, insomnia, dyspepsia etc.It refers to, due under being in nervous and pressure for a long time, occur spirit easily excitement and mental easy tired phenomenon, often with emotion worry, irritability, sleep disorder, muscle tone pain etc.; These symptoms can not be attributed to brain, physical disease and other mental sickness.Heavy time light during symptom, fluctuate relevant with psychosocial factor, the many delays of the course of disease.Current Most scholars thinks that Nervous and Mental Factors causes neurasthenic main cause.More every factors that can cause lasting buck fever and long-term intrapsychic conflict, make strong and lasting in tension of neural activity process, exceed the tolerance limit of nervous system tension force, neurasthenia can occur.As overtired and to can not get rest be overstrain of excitatory process; Dissatisfied to present situation is then overstrain of inhibitory process; Frequent change living environment and don't adaptation, the activity of central nervous system, plays a leading role in body Activities.And corticocerebral neurocyte has quite high toleration, generally and be not easy to cause neurasthenia or exhaustion.After the mental work of anxiety, although the fatigue of creating, just can recover after pausing to have a rest or sleep, but the neural activity of strong tense situation, once surmount tolerance limit, just may produce neurasthenia.For this reason, be bursting to develop and manyly treat the needs that neurasthenic medicine meets clinical treatment safely and effectively.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of neurasthenia.In order to reach this object, adopt following technical scheme:
Technical scheme: one is used for the treatment of neurasthenic pharmaceutical preparation, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Rhizoma seu herba Asystasiellae Chinensis 20 parts, geum aleppicum 25 parts, Rhizoma alpiniae pumilae 18 parts, buttonbush 25 parts, Radix Salviae Miltiorrhizae 25 parts, the Radix Astragali 28 parts, Semen Ziziphi Spinosae 15 parts, Radix Polygalae 15 parts, Rhizoma Acori Graminei 20 parts, Fructus Schisandrae Chinensis 25 parts, Poria cum Radix Pini 20 parts, Fructus Lycii 25 parts, Semen Coicis 20 parts, Fructus Corni 15 parts, Flos Chrysanthemi 15 parts, Ramulus Uncariae Cum Uncis 15 parts, Caulis Polygoni Multiflori 25 parts, Caulis Spatholobi 15 parts, 5 parts, Radix Glycyrrhizae.
Describedly be used for the treatment of neurasthenic pharmaceutical preparation, dosage form is pharmaceutically acceptable granule, tablet, capsule.
Describedly be used for the treatment of neurasthenic pharmaceutical preparation, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
Describedly be used for the treatment of the application of neurasthenic pharmaceutical preparation in preparation treatment neurasthenia medicine.
Rhizoma seu herba Asystasiellae Chinensis, Classification system: Asystasiellaneesiana (Wall.) Lindau, for Acanthaceae Rhizoma seu herba Asystasiellae Chinensis belongs to herbaceous plant.White, rich mucus, blade papery, Hua Dansheng or to life; Corolla lilac red.Medicinal source is rhizome or the herb of Rhizoma seu herba Asystasiellae Chinensis.Heat-clearing and toxic substances removing, dissipating blood stasis stops blooding, diuresis.For pulmonary tuberculosis, laryngopharynx swelling and pain, diabetes, ascites; Traumatic hemorrhage is controlled in external, sprains, furuncle and phyma.The present invention adopts all herbal medicine.
Geum aleppicum is Rosaceae avens geum aleppicum GeumaleppicumJacq., is used as medicine with herb or root.Summer excavates, and chopping is dried.Heat-clearing and toxic substances removing, reducing swelling and alleviating pain.For enteritis, dysentery, infantile convulsion, lumbago and skelalgia, traumatic injury, menoxenia, leucorrhea; Furuncle is controlled in external, carbuncle.The present invention is with all herbal medicine.
Rhizoma alpiniae pumilae is Zingiberaceae Alpinia plants Huashan Rhizoma Zingiberis Recens AlpiniachinensisRosc., is used as medicine with root stock.Summer excavates, and cleans and dries.Pungent, temperature.Expelling wind and removing dampness, vital energy regualting and blood circulation-promoting, removing toxic substances, pain relieving.Relieving cough and asthma, dispersing cold for relieving pain, except rheumatism, separates sore.For wind and cold cough with asthma, peratodynia, Fengshi Guanjie pain, falls and damages blood stasis stagnation, menoxenia, innominate toxic swelling.
Buttonbush is Rubiaceae Cephalanthus plant buttonbush CephalanthusnaucleoidesDC. [C.occidentalisauct.NonL.], is used as medicine with root, leaf and inflorescence.Xia Qiu gathers, and cleans, using fresh herb or dry.Root: heat-clearing and toxic substances removing, eliminating stasis to stop pain, hemostasia and promoting granulation, expelling phlegm for arresting cough.For influenza, upper respiratory tract infection, laryngopharynx swelling and pain, pneumonia, cough, orchitis, parotitis, mastitis; Traumatic injury is controlled in external, furuncle and phyma, fracture (or with root bark steeping in wine 1 ~ 2 day, dry grind into powder deposited, can hemostasis and pain-relieving).Inflorescence: clearing away heat-damp and promoting diuresis.For enteritis, bacillary dysentery.Leaf: heat-clearing and toxic substances removing.Traumatic injury is controlled in external, fracture.The present invention is used as medicine with root.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: the traditional Chinese medical science is thought, neurasthenia belongs to the category such as " melancholia ", " being insomnia ", " cardiopalmus " of the traditional Chinese medical science, Rhizoma seu herba Asystasiellae Chinensis of the present invention, geum aleppicum, Rhizoma alpiniae pumilae, buttonbush, Radix Salviae Miltiorrhizae, the Radix Astragali, Semen Ziziphi Spinosae, Radix Polygalae, Rhizoma Acori Graminei, Fructus Schisandrae Chinensis, Poria cum Radix Pini's heat-clearing and toxic substances removing, tranquillizing and allaying excitement are monarch drug, Fructus Lycii, Semen Coicis, Fructus Corni, Flos Chrysanthemi, Ramulus Uncariae Cum Uncis, Caulis Polygoni Multiflori, Caulis Spatholobi depressed liver-energy dispersing and QI regulating, wind-dispelling heat-dissipating are ministerial drug, Radix Glycyrrhizae is adjuvant, the mutual compatibility of full side, treatment neurasthenia successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get Rhizoma seu herba Asystasiellae Chinensis 20g, geum aleppicum 25g, Rhizoma alpiniae pumilae 18g, buttonbush 25g, Radix Salviae Miltiorrhizae 25g, Radix Astragali 28g, Semen Ziziphi Spinosae 15g, Radix Polygalae 15g, Rhizoma Acori Graminei 20g, Fructus Schisandrae Chinensis 25g, Poria cum Radix Pini 20g, Fructus Lycii 25g, Semen Coicis 20g, Fructus Corni 15g, Flos Chrysanthemi 15g, Ramulus Uncariae Cum Uncis 15g, Caulis Polygoni Multiflori 25g, Caulis Spatholobi 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, and atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get Rhizoma seu herba Asystasiellae Chinensis 20g, geum aleppicum 25g, Rhizoma alpiniae pumilae 18g, buttonbush 25g, Radix Salviae Miltiorrhizae 25g, Radix Astragali 28g, Semen Ziziphi Spinosae 15g, Radix Polygalae 15g, Rhizoma Acori Graminei 20g, Fructus Schisandrae Chinensis 25g, Poria cum Radix Pini 20g, Fructus Lycii 25g, Semen Coicis 20g, Fructus Corni 15g, Flos Chrysanthemi 15g, Ramulus Uncariae Cum Uncis 15g, Caulis Polygoni Multiflori 25g, Caulis Spatholobi 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds dextrin 50g, granulates, tabletting, makes tablet.
3, the preparation of capsule embodiment: get Rhizoma seu herba Asystasiellae Chinensis 20g, geum aleppicum 25g, Rhizoma alpiniae pumilae 18g, buttonbush 25g, Radix Salviae Miltiorrhizae 25g, Radix Astragali 28g, Semen Ziziphi Spinosae 15g, Radix Polygalae 15g, Rhizoma Acori Graminei 20g, Fructus Schisandrae Chinensis 25g, Poria cum Radix Pini 20g, Fructus Lycii 25g, Semen Coicis 20g, Fructus Corni 15g, Flos Chrysanthemi 15g, Ramulus Uncariae Cum Uncis 15g, Caulis Polygoni Multiflori 25g, Caulis Spatholobi 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds starch 50g, granulates, fill, makes capsule.
4, pharmaceutical preparation treatment neurasthenia of the present invention clinical research
4.1 general data: this pharmaceutical preparation is applied to clinical observation neurasthenia case 50 example, 35 ~ 64 years old age.The shortest person of the course of disease 1 month, most elder reaches 5 years.
4.2 diagnostic criterias: (1) head tonicity is uncomfortable: as dizziness, feeling of fullness in the head and headache etc.(2) sleep disorder: great majority are insomnias, and minority shows as drowsiness dreaminess, still tired after sleeping.(3) mental work rate declines: being mainly mental work can not be lasting, and attention can not be concentrated, memory disorder, is usually forgetful to general thing, and not easily forgets the thing of worry.(4) hyposthenia feeling of fatigue: show as general weakness, feeling of fatigue and labor intensity disproportionate.(5) mood is worried: be easily minor matter and excited, and with other Tenseness that mood worry causes, as nervous, inappetence etc.
4.3 test methods: prepare clinical sample by above-mentioned process for producing granula, specification is 10 grams every bag, within five days, is a course for the treatment of, one day three bags, take point early, middle and late three half an hour ante cibum.Period in a medicine is avoided eating anything raw or cold, pungent, stimulate and rotten thing.Blank group oral placebo granule five days is a course for the treatment of, one day three bags, point early, middle and late three half an hour ante cibum take.
4.4 criterions of therapeutical effect: recovery from illness: the transference cures such as tension headache, myalgia, sensory disturbance, emotion are tired.Effective: above-mentioned symptom is alleviated to some extent, physical recovery is healthy.Invalid: disease is unchanged.
4.5 therapeutic effect: in table 1.
Table 1 liang group comparitive study
| Group | n | Recovery from illness | Effectively | Invalid | Total effective rate (%) |
| Treatment group | 20 | 4 | 15 | 1 | 95 |
| Blank group | 20 | 2 | 1 | 17 | 15 |
Visible, the medicine that the present invention obtains can safe and effective treatment neurasthenia, and has no side effect.
Claims (4)
1. one kind is used for the treatment of neurasthenic pharmaceutical preparation, it is characterized in that, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Rhizoma seu herba Asystasiellae Chinensis 20 parts, geum aleppicum 25 parts, Rhizoma alpiniae pumilae 18 parts, buttonbush 25 parts, Radix Salviae Miltiorrhizae 25 parts, the Radix Astragali 28 parts, Semen Ziziphi Spinosae 15 parts, Radix Polygalae 15 parts, Rhizoma Acori Graminei 20 parts, Fructus Schisandrae Chinensis 25 parts, Poria cum Radix Pini 20 parts, Fructus Lycii 25 parts, Semen Coicis 20 parts, Fructus Corni 15 parts, Flos Chrysanthemi 15 parts, Ramulus Uncariae Cum Uncis 15 parts, Caulis Polygoni Multiflori 25 parts, Caulis Spatholobi 15 parts, 5 parts, Radix Glycyrrhizae.
2. be used for the treatment of neurasthenic pharmaceutical preparation as claimed in claim 1, it is characterized in that, dosage form is pharmaceutically acceptable granule, tablet, capsule.
3. be used for the treatment of neurasthenic pharmaceutical preparation as claimed in claim 1, it is characterized in that, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
4. be used for the treatment of the application of neurasthenic pharmaceutical preparation in treatment neurasthenia medicine according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510600726.3A CN105031481A (en) | 2015-09-18 | 2015-09-18 | Pharmaceutic preparation for treating neurasthenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510600726.3A CN105031481A (en) | 2015-09-18 | 2015-09-18 | Pharmaceutic preparation for treating neurasthenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105031481A true CN105031481A (en) | 2015-11-11 |
Family
ID=54438840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510600726.3A Pending CN105031481A (en) | 2015-09-18 | 2015-09-18 | Pharmaceutic preparation for treating neurasthenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105031481A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105232960A (en) * | 2015-11-15 | 2016-01-13 | 李洋 | Medicine preparation for treating neurasthenia |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686496A (en) * | 2005-04-13 | 2005-10-26 | 蒋希民 | Medicine for treating neurasthenia and its preparation method |
| CN101327296A (en) * | 2008-07-23 | 2008-12-24 | 武汉理工大学 | Compound traditional Chinese medicine preparation for treating and improving insomnia symptoms and preparation method thereof |
| CN101549088A (en) * | 2008-04-03 | 2009-10-07 | 北京中科仁和科技有限公司 | Traditional Chinese medicine for treating neurasthenia and preparation method thereof |
| CN101632760A (en) * | 2009-06-11 | 2010-01-27 | 杭州六易科技有限公司 | Method for preparing tea for relieving uneasiness |
-
2015
- 2015-09-18 CN CN201510600726.3A patent/CN105031481A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686496A (en) * | 2005-04-13 | 2005-10-26 | 蒋希民 | Medicine for treating neurasthenia and its preparation method |
| CN101549088A (en) * | 2008-04-03 | 2009-10-07 | 北京中科仁和科技有限公司 | Traditional Chinese medicine for treating neurasthenia and preparation method thereof |
| CN101327296A (en) * | 2008-07-23 | 2008-12-24 | 武汉理工大学 | Compound traditional Chinese medicine preparation for treating and improving insomnia symptoms and preparation method thereof |
| CN101632760A (en) * | 2009-06-11 | 2010-01-27 | 杭州六易科技有限公司 | Method for preparing tea for relieving uneasiness |
Non-Patent Citations (1)
| Title |
|---|
| 伍冲寒: "逍遥散合归脾汤加减治疗神经衰弱32例临床观察", 《中医药导报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105232960A (en) * | 2015-11-15 | 2016-01-13 | 李洋 | Medicine preparation for treating neurasthenia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101513437A (en) | Antifatigue Chinese pharmaceutical composition and preparation method thereof | |
| CN104922388A (en) | Medicinal preparation for treating female climacteric syndromes | |
| CN105147905A (en) | Medicinal preparation used for tranquilizing mind by nourishing heart | |
| CN105106627A (en) | Medicinal preparation for treating diabetes | |
| CN104906366A (en) | Pharmaceutical preparation for treating delayed menorrhea | |
| CN105106547A (en) | Pharmaceutic preparation for treating neurasthenia | |
| CN105055924A (en) | Medicine preparation used for treating migraine | |
| CN104906310A (en) | Medicine granules for treating neurasthenia | |
| CN104873879A (en) | Medicinal preparation for treating insomnia | |
| CN104888080A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN105079674A (en) | Medicinal preparation for treating chest stuffiness and pains | |
| CN105055845A (en) | Medicine preparation for treating cardiac insufficiency | |
| CN105106764A (en) | Medicinal preparation for treating vomitus gravidarum | |
| CN105148025A (en) | Pharmaceutical preparation for treating hyperlipidemia | |
| CN105106540A (en) | Medicinal preparation for treating cerebral thrombosis | |
| CN104800497A (en) | Traditional Chinese medicine composition for treating irregular menstruation of gynecology | |
| CN105079717A (en) | Pharmaceutical preparation for treating depression | |
| CN105288285A (en) | Medicinal preparation for treating chronic bronchitis | |
| CN105106646A (en) | Medicinal preparation for treating chronic pharyngitis | |
| CN105148078A (en) | Medicinal preparation used for treating oral ulcers | |
| CN105148074A (en) | Medicinal preparation used for treating diabetes | |
| CN105031050A (en) | Pharmaceutic preparation for treating flatulency | |
| CN105106684A (en) | Pharmaceutical preparation for treating liver-yang hyperactivity type hypertension | |
| CN104840759A (en) | Medicine preparation used for treating dyspepsia | |
| CN104998114A (en) | Medicine granule used for treating neurasthenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |